Newron Pharmaceuticals S.p.A. (NP5.F)
Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
At close: 09:15AM CEST
| Previous Close | 6.93 |
| Open | 6.94 |
| Bid | 7.25 x 0 |
| Ask | 7.46 x 0 |
| Day's Range | 6.92 - 6.94 |
| 52 Week Range | 3.84 - 12.50 |
| Volume | |
| Avg. Volume | 914 |
| Market Cap | 138.543M |
| Beta (5Y Monthly) | 0.70 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.91 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
Business WireData from Newron’s study 014/015 and an evenamide clinical development outlook presented at the 2024 Annual Congress of the Schizophrenia International Research Society (SIRS)
MILAN, April 08, 2024--Newron presents existing evenamide study 014/015 data and future clinical development outlook for evenamide at 2024 SIRS Congress in Florence, Italy
Business WireNewron Presents 2023 Financial Results and Provides 2024 Outlook
MILAN, March 19, 2024--Newron Pharmaceuticals announces 2023 year-end financial results and provides 2024 business outlook.
Business WireNewron announces agreement with the European Investment Bank (EIB) to extend the near-term tranche repayment dates of its 2018 financing agreement
MILAN, March 15, 2024--Newron announces agreement with the European Investment Bank (EIB) to extend the near-term tranche repayment dates of its 2018 financing agreement
© 2024 Yahoo. All rights reserved.